NPCE — Neuropace Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Neuropace, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	116	77.4	66.5	52.8	61.1
Net Total Accounts Receivable
Net Total Receivables	7.09	7.48	12.3	12.9	14.7
Total Inventory
Prepaid Expenses
Total Current Assets	133	97.7	92.7	81.3	94.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.603	15.9	14.4	12.9	11.3
Other Long Term Assets
Total Assets	134	114	108	94.6	106
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.3	11	16.2	15.2	17.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	60.1	79.3	87	86.6	86.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	73.5	34.8	20.7	8.01	19
Total Liabilities & Shareholders' Equity	134	114	108	94.6	106
Total Common Shares Outstanding